'Critical Path' Projects Aim to Advance Product Innovation

As part of its Critical Path initiative, FDA has released a list of 76 high-priority research projects designed to modernize and advance medical product development. The program aims to bring medical innovations to patients faster and at a lower cost. As part of the initiative, FDA and the Critical Path Institute have formed a consortium with five drug companies to share information that will help predict the safety of new treatments before they are tested in humans.

• Critical Path priority research projects
• Critical Path opportunities list